PTHS — Pelthos Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Pelthos Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	—	0.055	0.096	0.513	18
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	8.86
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0	0.055	0.096	1.37	53.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	—	12.8
Net Goodwill
Net Intangible Assets
Total Assets	0	0.055	0.096	1.37	130
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.58	3.76	6.54	4.08	26
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.68	3.76	6.54	4.08	91.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-3.68	-3.71	-6.44	-2.71	38.9
Total Liabilities & Shareholders' Equity	0	0.055	0.096	1.37	130
Total Common Shares Outstanding
Total Preferred Shares Outstanding